Commentary

Article

State of the Science Summit - Lung Cancer: Chaired by Kathryn F Mileham, MD, FACP, FASCO

State of the Science Summit - Lung Cancer: Chaired by Kathryn F Mileham, MD, FACP, FASCO.

State of the Science Summit - Lung Cancer: Chaired by Kathryn F Mileham, MD, FACP, FASCO

Speakers

  • Christopher Pallas, MD | Atrium Health Levine Cancer Institute
  • Daniel Haggstrom, MD | Atrium Health Levine Cancer Institute
  • Daniel Carrizosa, MD, MS | Atrium Health Levine Cancer Institute
  • John Heinzerling, MD | Atrium Health Levine Cancer Institute
  • Z. Luke Farmer, MD | Atrium Health Levine Cancer Institute

Topics

  • Perioperative Strategies in NSCLC
  • Targeting EGFR and ALK+ NSCLC
  • Emerging Targeted Therapies for NSCLC
  • Antibody-Drug Conjugates (ADC) in NSCLC
  • Community Clinical Scenarios: NSCLC
  • Recent Advances in Limited Stage SCLC

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Marina Chiara Garassino, MD
Nicolas Girard, MD
Benjamin Besse, MD, PhD, director, clinical research, Gustave Roussy Institute; professor, medical oncology, Paris-Saclay University
Nicolas Girard, MD
Shirish M. Gadgeel, MD
Jacob Sands, MD
Real world evidence of treatment practices and therapeutic outcomes for newly diagnosed NSCLC patients with non-classical EGFR mutations demonstrates high unmet medical need
Phase 1 trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3 Positive Tumors: Patients with LCNEC
Charu Aggarwal, MD, MPH, FASCO
Andrea Wolf, MD, MPH